Pharmaceutics | Free Full-Text | “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity | Neuropsychopharmacology
Exploring CB1, CB2 in Various Neurological Conditions
IJMS | Free Full-Text | Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
IJMS | Free Full-Text | New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling | Neuropsychopharmacology
Neurobiological Interactions Between Stress and the Endocannabinoid System | Neuropsychopharmacology
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain | Neuropsychopharmacology
Frontiers | Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease
High-resolution crystal structure of the human CB1 cannabinoid receptor | Nature
The endocannabinoid system and its therapeutic exploitation | Nature Reviews Drug Discovery
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system | PLOS ONE
Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands | ACS Chemical Neuroscience
Endocannabinoid signalling and the deteriorating brain | Nature Reviews Neuroscience
Cannabinoids and the expanded endocannabinoid system in neurological disorders | Nature Reviews Neurology
IJMS | Free Full-Text | Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
The Cannabinoid CB1 Receptor in Schizophrenia - Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
Frontiers | Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)
Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy | Nature Reviews Neuroscience
CB1-receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination | eLife
IJMS | Free Full-Text | Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Frontiers | Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain | Neuropsychopharmacology
mTORC1 and CB1 receptor signaling regulate excitatory glutamatergic inputs onto the hypothalamic paraventricular nucleus in response to energy availability - ScienceDirect
